Daniel J. Brennan - 01 Mar 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP and CFO
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 01 Mar 2023
Net transactions value: -$4,210,457
Form type: 4
Filing time: 02 Mar 2023, 16:01:01 UTC
Previous filing: 22 Feb 2023
Next filing: 02 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$291,055	+16,863	+5.9%	$17.26	302,821	01 Mar 2023	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$246,053	+15,086	+5%	$16.31	317,907	01 Mar 2023	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$178,686	+13,661	+4.3%	$13.08	331,568	01 Mar 2023	Direct	F1
transaction	BSX	Common Stock	Sale	$3,526,337	-75,610	-23%	$46.64	255,958	01 Mar 2023	Direct	F1, F2
transaction	BSX	Common Stock	Sale	$1,399,914	-30,000	-12%	$46.66	225,958	02 Mar 2023	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-16,863	-33%	$0.000000	33,728	01 Mar 2023	Common Stock	16,863	$17.26	Direct	F1, F4
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-15,086	-33%	$0.000000	30,173	01 Mar 2023	Common Stock	15,086	$16.31	Direct	F1, F5
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-13,661	-50%	$0.000000	13,662	01 Mar 2023	Common Stock	13,661	$13.08	Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.437 to $46.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.575 to $46.74, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F5	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F6	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.